[Retracted] Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma

Table 3

Association of ferroptosis-related lncRNAs with UCEC clinical characteristics.

Characteristic	Low expression of CFAP58-DT	High expression of CFAP58-DT		Low expression of EMSLR	High expression of EMSLR		Low expression of ADIRF-AS1	High expression of ADIRF-AS1		Low expression of CDKN2B-AS1	High expression of CDKN2B-AS1
	276	276		276	276		276	276		276	276
Clinical stage, (%)			0.201			<0.001			0.006			0.045
Stage I	182 (33%)	160 (29%)		197 (35.7%)	145 (26.3%)		191 (34.6%)	151 (27.4%)		186 (33.7%)	156 (28.3%)
Stage II	25 (4.5%)	26 (4.7%)		17 (3.1%)	34 (6.2%)		22 (4%)	29 (5.3%)		25 (4.5%)	26 (4.7%)
Stage III	58 (10.5%)	72 (13%)		56 (10.1%)	74 (13.4%)		51 (9.2%)	79 (14.3%)		54 (9.8%)	76 (13.8%)
Stage IV	11 (2%)	18 (3.3%)		6 (1.1%)	23 (4.2%)		12 (2.2%)	17 (3.1%)		11 (2%)	18 (3.3%)
Age, (%)			<0.001			0.007			<0.001			<0.001
≤60	123 (22.4%)	83 (15.1%)		119 (21.7%)	87 (15.8%)		123 (22.4%)	83 (15.1%)		132 (24%)	74 (13.5%)
>60	151 (27.5%)	192 (35%)		156 (28.4%)	187 (34.1%)		151 (27.5%)	192 (35%)		141 (25.7%)	202 (36.8%)
Histologic grade, (%)			<0.001			<0.001			<0.001			<0.001
G1	66 (12.2%)	32 (5.9%)		75 (13.9%)	23 (4.3%)		60 (11.1%)	38 (7%)		47 (8.7%)	51 (9.4%)
G2	73 (13.5%)	47 (8.7%)		80 (14.8%)	40 (7.4%)		78 (14.4%)	42 (7.8%)		81 (15%)	39 (7.2%)
G3	129 (23.8%)	194 (35.9%)		118 (21.8%)	205 (37.9%)		135 (25%)	188 (34.8%)		145 (26.8%)	178 (32.9%)
OS event, (%)			0.054			0.031			0.017			0.054
Alive	238 (43.1%)	220 (39.9%)		239 (43.3%)	219 (39.7%)		240 (43.5%)	218 (39.5%)		238 (43.1%)	220 (39.9%)
Dead	38 (6.9%)	56 (10.1%)		37 (6.7%)	57 (10.3%)		36 (6.5%)	58 (10.5%)		38 (6.9%)	56 (10.1%)
Histological type, (%)			0.024			<0.001			<0.001			<0.001
Endometrioid	219 (39.7%)	191 (34.6%)		234 (42.4%)	176 (31.9%)		246 (44.6%)	164 (29.7%)		249 (45.1%)	161 (29.2%)
Mixed	10 (1.8%)	14 (2.5%)		10 (1.8%)	14 (2.5%)		7 (1.3%)	17 (3.1%)		5 (0.9%)	19 (3.4%)
Serous	47 (8.5%)	71 (12.9%)		32 (5.8%)	86 (15.6%)		23 (4.2%)	95 (17.2%)		22 (4%)	96 (17.4%)
Age, median (IQR)	61 (56, 70.75)	65 (60, 72)	0.003	62 (56, 70)	65 (58, 73)	0.004	63 (55, 71)	64 (60, 72)	0.004	62 (54, 69)	66 (60, 72)	<0.001